TES Pharma presents new treatment approach...TES Pharma has presented a novel treatment approach for acute kidney injury and non-alcoholic fatty liver disease in Nature. more ➔
MEPs vote for ban of single-use plasticsThe European Parliament has approved measures that could lead to a ban of the top 10 single use plastic products that contribute to marine littering by 2021. more ➔
AstraZeneca and Innate Pharma in US$5bn on...AstraZeneca plc has extended its immunoncology pipeline by an extension of its partnership with French Innate Pharma SA. more ➔
Takeda strikes US$640m deal with EnteromeFrench Enterome SA has added a second licence agreement with Takeda to its deal portfolio, projecting possible payments of US$640m. more ➔
EMA recommends four biologicals for marketThe European Medicines Agency delays the EU approval of Nivolumab/Ipilimumab in NSCLC and greenlights four biotherapeutics to be marketed in the EU. more ➔
Companies at EFIB set to drive the bioecon...Industrial biotech innovations, presented in at the 11th EFIB in Toulouse, could become the key enabler set to save our planet if supported appropriately. more ➔
Oxford Nanopore wins over AmgenOxford Nanopore Technologies has impressed Amgen with its genetic sequencing technology. The US biopharma major has invested £50m in the Oxford-based company. more ➔
French Acticor Biotech raises €15.3mIn a Series B financing round, INSERM spin-off Acticor Biotech has raised €15.3m from European and Asian investors. The new financing will go towards the launch off the first Phase II clinical … more ➔
HiFiBiO bags immuno-oncology specialist H-...Multinational biotherapeutics company HiFiBiO Therapeutics announced that it has taken over early stage biotech H-Immune Therapeutics. With the acquisition of the French Atomic Energy Commission spin-out, … more ➔
Phase III success for Roche breast cancer...Roche has announced that in a Phase III trial, its antibody-drug conjugate Kadcyla showed improved invasive disease-free survival in breast cancer patients. more ➔
